The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
Filters: Collection: "ehsl_novel_nam"
| Title | Creator | Relation Is Part Of | ||
|---|---|---|---|---|
| 1 |
 |
Should I Have Teprotumumab or Surgery? | Alison V. Crum, MD | NANOS Annual Meeting 2023: Ophthalmic Surgery in the Neuro-Ophthalmic Patient: https://novel.utah.edu/collection/NAM/toc/ |
| 2 |
 |
Should I Have Teprotumumab or Surgery? | Alison V. Crum, MD | NANOS Annual Meeting 2023: Ophthalmic Surgery in the Neuro-Ophthalmic Patient: https://novel.utah.edu/collection/NAM/toc/ |
| 3 |
 |
Should I Have Teprotumumab or Surgery? | Alison V. Crum | NANOS Annual Meeting 2023: Ophthalmic Surgery in the Neuro-Ophthalmic Patient |
| 4 |
 |
Thyroid Eye Disease - Pilot Study | Nicholas E. Frisard; Anne P. Rowland; Marie D. Acierno; Kimberly P. Cockerham; Adham Al Hariri | NANOS 2013: Poster Presentations |
| 5 |
 |
Ocular Motility in Thyroid Eye Disease Evaluation and Surgery | Steven E. Feldon, MD, MBA | NANOS 2010: IV Thyroid Eye Disease Update |
| 6 |
 |
Ocular Motility in Thyroid Eye Disease Evaluation and Surgery | Steven E. Feldon, MD, MBA | NANOS 2010: IV Thyroid Eye Disease Update |
| 7 |
 |
Thyroid Eye Disease in Young Patients Compared with Older | Ruth Huna-Baron; Gaby Katz; Hana Leiba; Biatrix Hadas; Guy J. Ben Simon | NANOS 2010: Poster Presentations |
| 8 |
 |
Efficacy of Restasis(R) (0.05% Cyclosporine A) Ophthalmic Emulsion in Patients with Thyroid Eye Disease (TED) | Lauren Crow; Kimberly Cockerham; Jing Li | NANOS 2007: Poster Presentations |
| 9 |
 |
Development of Increased Vertical Fusional Amplitudes in Patients with Thyroid Eye Disease | Dane Breker; Wayne Cornblath | NANOS 2012: Poster Presentations |
| 10 |
 |
Quantifying Success of Radiation Therapy for Thyroid Optic Neuropathy | Rochelle S. Zak, MD; J. Winterkorn, PhD, MD; S. Rush MD | NANOS 1996: Scientific Platform Presentations (Session 1) |
| 11 |
 |
Immunology of Thyroid Eye Disease | Steven Feldon, MD; Richard Phipps, PhD | NANOS 2007: Immunological Diseases in Neuro-Ophthalmology |
| 12 |
 |
Adult with Acquired Oblique Diplopia: Do I Image? Do I Operate? (PDF) | Hilda Capó, MD | NANOS Annual Meeting 2020: Strabismus: Image? Operate? |
| 13 |
 |
Orbital Fibroblasts From Thyroid Eye Disease Patients Differ In Proliferative And Adipogenic Responses Depending On Disease Sub-type | Ajay E. Kuriyan; Collynn F. Woeller; Charles W. O'Loughlin; Richard P. Phipps; Steven E. Feldon | NANOS 2014: Scientific Platform Presentations (Session 2) |
| 14 |
 |
Orbital Fibroblasts From Thyroid Eye Disease Patients Differ In Proliferative And Adipogenic Responses Depending On Disease Sub-type | Ajay E. Kuriyan; Collynn F. Woeller; Charles W. O'Loughlin; Richard P. Phipps; Steven E. Feldon | NANOS 2014: Scientific Platform Presentations (Session 2) |
| 15 |
 |
Teprotumumab Efficacy in Retreatment and Longer-Term Thyroid Eye Disease: OPTIC-X Study Results | Raymond S, Douglas; Saba Sile; Terry J. Smith; George J. Kahaly | NANOS Annual Meeting 2021: Scientific Platform Session I |
| 16 |
 |
Checkpoint inhibitor associated orbital inflammation masquerading as ocular myasthenia gravis and thyroid eye disease | Marisa Tieger; Eric Gaier; Sashank Prasad; Michael Yoon | NAM 2019: Poster Session I: Clinical Highlights in Neuro-Ophthalmology |
| 17 |
 |
Water Disease | Lejla Mutapcic-Vajzovic; Byron Lam; Sander Dubovy; Andrew Kao; Thomas Johnson | NANOS 2011: Poster Presentations |
| 18 |
 |
Objective Markers for Thyroid Eye Disease (TED) Activity, Severity 387 and Progression | Kimberly P. Cockerham, MD, FACS | NANOS 2010: IV Thyroid Eye Disease Update |
| 19 |
 |
Objective Markers for Thyroid Eye Disease (TED) Activity, Severity 387 and Progression | Kimberly P. Cockerham, MD, FACS | NANOS 2010: IV Thyroid Eye Disease Update |
| 20 |
 |
TED Treatment: Today's Options | Andrea Lora Kossler, MD, FACS | NANOS Annual Meeting 2023: Thyroid Eye Disease: Hiding in Plain Sight?: https://novel.utah.edu/collection/NAM/toc/ |
| 21 |
 |
Orbital Ultrasound as the Primary Imaging Modality in Patients with Ocular Misalignment and Suspected Thyroid Eye Disease | Nicholas J. Volpe, MD; James Sbarbaro; E. Kym Gendron; Grant Liu, MD; Steven Galetta, MD; Laura Balcer, MD, MCE | NANOS 2003: Scientific Platforms Presentations II |
| 22 |
 |
Extraocular Muscle Enlargement in Thyroid Eye Disease Using Volumetric Analysis | Kristen Park; Joyce Wen; Joy Li; Shirley Li; Johnny Lee; Kimberly Gokoffski; Alexander Lerner; Vishal Patel; Sandy Zhang-Nunes; Jessica Chang | NANOS Annual Meeting 2023: Poster Session II: Ocular-Imaging |
| 23 |
 |
Sustainability of Teprotumumab Efficacy in Thyroid Eye Disease | Prem S. Subramanian; Saba Sile; Robert Holt; Raymond Douglas | NANOS Annual Meeting 2022: Scientific Platform III |
| 24 |
 |
All Signs Point to Giant Cell Arteritis | Dmitry Balian; Brooke Johnson; Peter MacIntosh | NANOS Annual Meeting 2020: Poster Session I: Clinical Highlights |
| 25 |
 |
Eyetracking in Pediatric Multiple Sclerosis | Andrew Yousef; Michael Deveruex; Pierre-Antoine Gourraud; Soren Jonzzon; Leena Suleiman; Janet Chong; Emmanuelle Waubant; Ari Green; Jennifer Graves | NANOS 2018: Poster Presentations |